T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -51,153 | -62,428 | -54,804 | -45,290 | -31,390 |
| Depreciation Amortization | 2,449 | 2,940 | 2,280 | 1,465 | 691 |
| Accounts receivable | -1,319 | -140 | 42 | -168 | -201 |
| Accounts payable and accrued liabilities | 121 | -314 | -61 | 177 | -208 |
| Other Working Capital | -3,943 | -424 | 808 | 1,957 | 744 |
| Other Operating Activity | 13,707 | 12,648 | 5,293 | 4,394 | 2,180 |
| Operating Cash Flow | $-40,138 | $-47,718 | $-46,442 | $-37,465 | $-28,184 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -593 | -2,476 | -5,487 | -7,974 | -2,084 |
| Other Investing Activity | 0 | 0 | 0 | 80 | 0 |
| Investing Cash Flow | $-593 | $-2,476 | $-5,487 | $-7,894 | $-2,084 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 43,803 | 10,000 | 19,714 |
| Debt Repayment | -1,547 | -1,194 | -32,404 | -309 | -4,037 |
| Common Stock Issued | 51,204 | 19,699 | 633 | 35,481 | 58,242 |
| Other Financing Activity | 0 | 0 | 39,723 | 0 | 0 |
| Financing Cash Flow | $49,657 | $18,505 | $51,755 | $45,172 | $73,919 |
| Beginning Cash Position | 42,059 | 73,748 | 73,922 | 73,849 | 30,198 |
| End Cash Position | 50,985 | 42,059 | 73,748 | 73,662 | 73,849 |
| Net Cash Flow | $8,926 | $-31,689 | $-174 | $-187 | $43,651 |
| Free Cash Flow | |||||
| Operating Cash Flow | -40,138 | -47,718 | -46,442 | -37,465 | -28,184 |
| Capital Expenditure | -593 | -2,476 | -5,487 | -7,974 | -2,084 |
| Free Cash Flow | -40,731 | -50,194 | -51,929 | -45,439 | -30,268 |